With our updated Best Practices for Management of Infants with Neonatal Abstinence Syndrome (NAS), ProgenyHealth addresses some of the newest treatment methods, medication doses, transition of care needs, and long-term concerns for these infants.
Neonatal drug withdrawal can occur when newborn infants are exposed to medications or addictive substances in-utero or can occur following prolonged postnatal exposure.
